Eurointervention

Article	Citations
Transcatheter treatment for tricuspid valve disease	181
Percutaneous coronary intervention for bifurcation coronary lesions: the 15<sup>th</sup> consensus document from the European Bifurcation Club	148
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcircula	115
Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI – design and rationale of ILUMIEN IV: OPTIMAL PCI	85
Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism&nbsp;	76
Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques	74
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	58
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial	55
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients	55
Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial	54
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	52
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry	51
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	48
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation	48
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study	45
Ultrasound-guided access to the distal radial artery at the anatomical snuffbox for catheter-based vascular interventions: a technical guide	43
Management of cardiogenic shock	41
A deep learning algorithm for detecting acute myocardial infarction	39
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis	38
Transcatheter aortic valve implantation in degenerated surgical aortic valves	37
Training and validation of a deep learning architecture for the automatic analysis of coronary angiography	37
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study	37
Recanalisation of coronary chronic total occlusions	36
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial	35
Mitral valve transcatheter edge-to-edge repair	32

Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions	32
Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease	32
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry	32
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis	32
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	31
Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study	30
National French registry of spontaneous coronary artery dissections: prevalence of fibromuscular dysplasia and genetic analyses	30
Principles and pitfalls in coronary vasomotor function testing	30
Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study	28
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification	28
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions	26
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	26
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial	25
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2	25
Reproducibility of quantitative flow ratio: the QREP study	24
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing	23
Device-related thrombus following left atrial appendage occlusion	23
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation	22
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis	22
Safety of absolute coronary flow and microvascular resistance measurements by thermodilution	22
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	22
Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)	22
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	22
A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation	21
Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study	21
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	21
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	21
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc	21
Clinical outcomes by angiographic type of spontaneous coronary artery dissection	21
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair	21
Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry	20
Transseptal puncture: procedural guidance, challenging situations and management of complications	20
Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry	20
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial	19
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications	19
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	19
A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous	19
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	18
Echocardiographic guidance in transcatheter structural cardiac interventions	18
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study	18
Device entrapment during percutaneous coronary intervention of chronic total occlusions: incidence and management strategies	18
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture	18
Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices	17
Heterogeneity of debris captured by cerebral embolic protection filters during TAVI	16
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation	16
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial	15
Robotics, imaging, and artificial intelligence in the catheterisation laboratory	15
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification	15
Coronary artery cannulation after transcatheter aortic valve implantation	15
Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial	14

Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study	14
Outcomes of directional atherectomy for common femoral artery disease	14
Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series	14
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial	14
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance	14
Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial	14
Near-infrared spectroscopy carotid plaque characteristics and cerebral embolism in carotid artery stenting	13
Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis	13
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation	13
Radial artery dilatation to improve access and lower complications during coronary angiography: the RADIAL trial	13
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	13
Lipid-lowering therapy and percutaneous coronary interventions	13
Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study	13
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	13
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	13
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	13
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)	13
Transient acute right coronary artery deformation during transcatheter interventional tricuspid repair with the Cardioband tricuspid system	12
Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials	12
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	12
Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents	12
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention	12
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	12
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	12
Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation	11
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease	11
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial	11
Long-term changes in coronary physiology after aortic valve replacement	11
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	11
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary	11
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	11
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak	11
Targeting inflammation in atherosclerosis: overview, strategy and directions	11
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules	11
Predictors and clinical impact of thrombosis after transcatheter mitral valve implantation using balloon-expandable bioprostheses	11
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	11
Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease	11
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation	11
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	10
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	10
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials	10
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial	10
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial	10
Management of patients with mitral regurgitation ineligible for standard therapy undergoing TMVI screening	10
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial	10
Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation	10
Impact of chronic total coronary occlusion revascularisation on infarct-related myocardial scars responsible for recurrent ventricular tachycardia	9
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry	9
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)	9
Transoesophageal echocardiography guidance with paediatric probes in adults undergoing left atrial appendage occlusion	9
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial	9
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	9
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	9
Consolidating the value of the standardised ARC-HBR definition	8
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow	8
Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial	8
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up	8
Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system	8
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	7
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	7
Cerebral embolic protection during transcatheter heart interventions	7
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry	7
Transcatheter valve repair in congenitally corrected transposition of the great arteries	7
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study	7
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	7
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	7
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of	7
Long-term safety of drug-coated devices for peripheral revascularisation	7
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation	7
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2	7
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience	7
Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review	7
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation	7
Deep sedation versus general anaesthesia for transcatheter mitral valve repair: an individual patient data meta-analysis of observational studies	7
Transcatheter valve-in-valve implantation versus redo surgical mitral valve replacement in patients with failed mitral bioprostheses	6
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry	6
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial	6
Transseptal puncture in patients with septal occluder devices during catheter ablation of atrial fibrillation	6
Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data metaanalysis from the femoral ultrasound trialist collaboration	6
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score	6

Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis	6
Histological examination of renal nerve distribution, density, and function in humans	6
Angiographic predictors of unplanned rotational atherectomy in complex calcified coronary artery disease: a pooled analysis from the randomised ROTAXUS and PREPARE-CALC trials	6
Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials	6
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study	6
Spontaneous echo contrast, left atrial appendage thrombus and stroke in patients undergoing transcatheter aortic valve implantation	6
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report	6
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion	5
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure	5
Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation	5
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	5
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	5
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial	5
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	5
Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy	5
Transcatheter interventions for heart failure	5
Clinical impact of intervention strategies after failed transcatheter mitral valve repair	5
Non-implant valve repair for calcific aortic stenosis: the Leaflex study	4
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty	4
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	4
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	4
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy	4
Fatal acute mesenteric ischaemia following transcatheter aortic valve replacement	4
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system	4
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	4
Outcomes of non-ischaemic coronary lesions with high-risk plaque characteristics on coronary CT angiography	4
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra	4
Cusp overlap technique during valve-in-valve TAVI using the novel Navitor transcatheter heart valve	4
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	4
Outcomes of excimer laser-contrast angioplasty for stent underexpansion	4
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	4
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation	4
Crush techniques for percutaneous coronary intervention of bifurcation lesions	4
Procedural and one-year outcomes of robotic-assisted versus manual percutaneous coronary intervention	4
Procedural and short-term outcomes of occluding large left atrial appendages with the LAmbre device	4
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation	4
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial	4
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)	4
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients	4
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	4
Pumping up best practices in radial artery access: prolonged occlusion flow-mediated dilation improves radial artery access success	4
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination	4
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial	4
Percutaneous mitral valve leaflet repair: ongoing directions and future perspectives	3
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation	3
Napkin ring formation in culotte stenting using current-generation drug-eluting stents in left main coronary artery bifurcation	3
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction	3
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	3
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	3
How to set up regional STEMI networks: a "Stent - Save a life!" initiative	3
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial	3
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	3
Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions	3
One-month DAPT after acute coronary syndrome: too short or not too short?	3
A direct wire pacing device for transcatheter heart valve and coronary interventions: a first-in-human, multicentre study of the Electroducer Sleeve	3
A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair	3
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?	3
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection	3
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial	3
Brachial arterial access for PCI: an analysis of the British Cardiovascular Intervention Society database	3
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study	3
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	3
Late structural discontinuity after bioresorbable vascular scaffold implantation in patients with in-stent restenosis	3
Thrombolysis in ST-elevation myocardial infarction is not dead	3
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation	2
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement	2
Transcatheter mitral valve implantation for native valve disease	2
Incorporating patients’ preferences into the Heart Team equation	2
Skating on thin ice: searching for vulnerable plaques	2
A novel robotic radiation shielding device for interventional cardiology procedures	2
Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry	2
To be better among the best: a difficult task	2
Transcatheter left ventriculoplasty	2
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	2
In search of the “IDEAL” left main coronary stent and DAPT regimen	2
Simulation-based planning of transcatheter left atrial appendage occlusion	2
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial	2
DAPT guided by platelet function tests or genotyping after PCI: pros and cons	2
Transcatheter paravalvular leak closure: catch me if you can	2
Paravalvular regurgitation after TAVI: the forgotten enemy	2
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons	2
A study of the novel SinoCrown system for transcatheter aortic valve implantation	2
Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction	2
Deep learning for prediction of fractional flow reserve from resting coronary pressure curves	2
Acute and one-year clinical outcomes of pre-stenting intravascular ultrasound: a patient-level meta-analysis of randomised clinical trials	2
Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study	2
One-year clinical outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL study	2
Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EA	2
TAVI at 20: how a crazy idea led to a clinical revolution	2
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial	2
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment	2
Reply: Composite endpoints in clinical trials - simplicity or perfection?	2